Clinical Trials Directory

Trials / Completed

CompletedNCT01490346

Tissue Drug Levels of HIV Medications

A Compartmental Analysis of HIV Reservoirs and Immune Reconstitution

Status
Completed
Phase
Study type
Observational
Enrollment
22 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to find out why HIV continues to make copies in people taking HIV drugs. The investigators want to know if the medications most people use to treat HIV get into the lymphatic tissue where HIV persists.

Conditions

Interventions

TypeNameDescription
DRUGInitiation of anti-retroviral therapySubjects begin taking a preferred initial anti-retroviral regimens as determined by their primary care provider. Intracellular levels of those medications are measured.

Timeline

Start date
2008-09-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2011-12-13
Last updated
2015-06-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01490346. Inclusion in this directory is not an endorsement.

Tissue Drug Levels of HIV Medications (NCT01490346) · Clinical Trials Directory